Puma Biotechnology, Inc. (PBYI)
NASDAQ: PBYI · Real-Time Price · USD
7.77
-0.31 (-3.84%)
Nov 13, 2026, 4:00 PM EST - Market closed
Puma Biotechnology Revenue
Puma Biotechnology had revenue of $55.06M in the quarter ending September 30, 2026, with 1.07% growth. This brings the company's total for the last twelve months to $231.83M, up 9.35% year-over-year. In the year 2025, Puma Biotechnology had annual revenue of $228.37M, down -0.91%. That makes Puma Biotechnology the 16,429th largest company in the world by revenue and 2,790th in the United States.
Revenue (ttm)
$231.83M
Revenue Growth
+9.35%
P/S Ratio
1.73
Revenue / Employee
$1,295,112
Employees
179
Market Cap
401.70M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 228.37M | -2.10M | -0.91% |
| Dec 31, 2024 | 230.47M | -5.17M | -2.19% |
| Dec 31, 2023 | 235.64M | 7.61M | 3.34% |
| Dec 31, 2022 | 228.03M | -25.12M | -9.92% |
| Dec 31, 2021 | 253.16M | 28.06M | 12.46% |
| Dec 31, 2020 | 225.10M | -47.16M | -17.32% |
| Dec 31, 2019 | 272.26M | 21.27M | 8.47% |
| Dec 31, 2018 | 250.99M | 223.31M | 806.60% |
| Dec 31, 2017 | 27.69M | - | - |
| Dec 31, 2016 | - | - | - |
| Dec 31, 2015 | - | - | - |
| Dec 31, 2014 | - | - | - |
| Dec 31, 2013 | - | - | - |
| Dec 31, 2012 | - | - | - |
| Dec 31, 2011 | - | - | - |
| Dec 31, 2010 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Alector | 173.47M |
| ARS Pharmaceuticals | 122.14M |
| Assembly Biosciences | 67.01M |
| Fennec Pharmaceuticals | 66.37M |
| Prothena Corporation | 52.74M |
| Opus Genetics | 7.91M |
| SL Science Holding | 3.27M |
PBYI News
- 9 days ago - Puma Biotechnology reports Q3 adjusted EPS 15c vs 21c last year - TheFly
- 9 days ago - Puma Biotechnology Earnings Call Transcript: Q3 2026 - Transcripts
- 9 days ago - Puma Biotechnology Earnings release: Q3 2026 - Filings
- 9 days ago - Puma Biotechnology Slides: Q3 2026 - Filings
- 9 days ago - Puma Biotechnology Quarterly report: Q3 2026 - Filings
- 9 days ago - Puma Biotechnology Reports Third Quarter 2026 Financial Results - Business Wire
- 10 days ago - Puma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 23 days ago - Puma Biotechnology to Host Conference Call to Discuss Third Quarter 2026 Financial Results - Business Wire